nodes	percent_of_prediction	percent_of_DWPC	metapath
Ingenol Mebutate—PRKCA—periosteum—cleft lip	0.0855	0.511	CbGeAlD
Ingenol Mebutate—PRKCD—telencephalon—cleft lip	0.0256	0.153	CbGeAlD
Ingenol Mebutate—PRKCA—embryo—cleft lip	0.0173	0.104	CbGeAlD
Ingenol Mebutate—PRKCD—head—cleft lip	0.0159	0.0952	CbGeAlD
Ingenol Mebutate—PRKCA—telencephalon—cleft lip	0.0141	0.0843	CbGeAlD
Ingenol Mebutate—PRKCA—head—cleft lip	0.00878	0.0525	CbGeAlD
Ingenol Mebutate—PRKCA—DAP12 interactions—FGF9—cleft lip	0.00137	0.00165	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—FGF9—cleft lip	0.00137	0.00165	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—FGF9—cleft lip	0.00136	0.00163	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—FGF9—cleft lip	0.00135	0.00162	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—FGF9—cleft lip	0.00134	0.00161	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling events mediated by VEGFR1 and VEGFR2—NOS3—cleft lip	0.00134	0.00161	CbGpPWpGaD
Ingenol Mebutate—PRKCD—NGF signalling via TRKA from the plasma membrane—FGFR1—cleft lip	0.00133	0.0016	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling of activated FGFR—FGF10—cleft lip	0.00133	0.00159	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—WNT9B—cleft lip	0.0013	0.00156	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—TGFB3—cleft lip	0.00129	0.00155	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—FGF7—cleft lip	0.00127	0.00153	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—FGF7—cleft lip	0.00127	0.00152	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Downstream signaling of activated FGFR—FGF2—cleft lip	0.00126	0.00152	CbGpPWpGaD
Ingenol Mebutate—PRKCD—NGF signalling via TRKA from the plasma membrane—FGFR3—cleft lip	0.00126	0.00151	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—FGF10—cleft lip	0.00125	0.0015	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—FGF3—cleft lip	0.00125	0.0015	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—FGF10—cleft lip	0.00124	0.00149	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—FGF10—cleft lip	0.00124	0.00148	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—FGF10—cleft lip	0.00123	0.00148	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—WNT3—cleft lip	0.00122	0.00147	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—FGF9—cleft lip	0.00121	0.00146	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Extracellular matrix organization—BMP4—cleft lip	0.00121	0.00145	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Myometrial Relaxation and Contraction Pathways—NOS3—cleft lip	0.00121	0.00145	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Downstream signal transduction—FGF2—cleft lip	0.00119	0.00142	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by FGFR—FGF2—cleft lip	0.00118	0.00142	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—FGF8—cleft lip	0.00118	0.00141	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—IRF6—cleft lip	0.00118	0.00141	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by ERBB2—FGF2—cleft lip	0.00117	0.00141	CbGpPWpGaD
Ingenol Mebutate—PRKCD—DAP12 signaling—FGF2—cleft lip	0.00117	0.0014	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—FGF8—cleft lip	0.00117	0.0014	CbGpPWpGaD
Ingenol Mebutate—PRKCD—EGF/EGFR Signaling Pathway—NOS3—cleft lip	0.00116	0.0014	CbGpPWpGaD
Ingenol Mebutate—PRKCD—B Cell Receptor Signaling Pathway—MYC—cleft lip	0.00116	0.0014	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—FGF10—cleft lip	0.00116	0.00139	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—FGF10—cleft lip	0.00116	0.00139	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—ABCA4—cleft lip	0.00116	0.00139	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—FGF10—cleft lip	0.00115	0.00138	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—FGF10—cleft lip	0.00114	0.00136	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—FGF10—cleft lip	0.00113	0.00136	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Wnt Signaling Pathway and Pluripotency—MYC—cleft lip	0.00112	0.00134	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—FGFR2—cleft lip	0.00111	0.00134	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—FGFR2—cleft lip	0.0011	0.00132	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Wnt Signaling Pathway Netpath—MYC—cleft lip	0.0011	0.00132	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by FGFR in disease—FGF2—cleft lip	0.0011	0.00132	CbGpPWpGaD
Ingenol Mebutate—PRKCD—DAP12 interactions—FGF2—cleft lip	0.0011	0.00132	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR—FGF2—cleft lip	0.00109	0.00131	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR in Cancer—FGF2—cleft lip	0.00108	0.0013	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by PDGF—FGF2—cleft lip	0.00108	0.00129	CbGpPWpGaD
Ingenol Mebutate—PRKCA—ErbB Signaling Pathway—MYC—cleft lip	0.00107	0.00128	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling of activated FGFR—FGFR2—cleft lip	0.00106	0.00128	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—SLC19A1—cleft lip	0.00106	0.00127	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Corticotropin-releasing hormone—NOS3—cleft lip	0.00105	0.00126	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—FGFR1—cleft lip	0.00104	0.00125	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—WNT3—cleft lip	0.00103	0.00124	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—FGFR1—cleft lip	0.00103	0.00123	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—FGF10—cleft lip	0.00102	0.00123	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—FGFR2—cleft lip	0.001	0.0012	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—FGFR2—cleft lip	0.000996	0.0012	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling of activated FGFR—FGFR1—cleft lip	0.000993	0.00119	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—FGFR2—cleft lip	0.000991	0.00119	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—FGFR2—cleft lip	0.000986	0.00118	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—FGFR3—cleft lip	0.00098	0.00118	CbGpPWpGaD
Ingenol Mebutate—PRKCD—NGF signalling via TRKA from the plasma membrane—FGF2—cleft lip	0.000974	0.00117	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—FGFR3—cleft lip	0.000969	0.00116	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—TYMS—cleft lip	0.000962	0.00116	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—FGF3—cleft lip	0.000958	0.00115	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—ARHGAP29—cleft lip	0.000951	0.00114	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—FGF3—cleft lip	0.000951	0.00114	CbGpPWpGaD
Ingenol Mebutate—PRKCD—PDGFR-beta signaling pathway—MYC—cleft lip	0.00095	0.00114	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling of activated FGFR—FGFR3—cleft lip	0.000938	0.00113	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—FGF9—cleft lip	0.000934	0.00112	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—FGFR1—cleft lip	0.000933	0.00112	CbGpPWpGaD
Ingenol Mebutate—PRKCA—VEGFA-VEGFR2 Pathway—NOS3—cleft lip	0.000932	0.00112	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—FGFR1—cleft lip	0.000928	0.00111	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—FGFR2—cleft lip	0.000928	0.00111	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—FGFR2—cleft lip	0.000928	0.00111	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—FGF9—cleft lip	0.000927	0.00111	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—FGFR1—cleft lip	0.000924	0.00111	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—FGFR2—cleft lip	0.00092	0.0011	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—FGFR1—cleft lip	0.000919	0.0011	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—FGFR2—cleft lip	0.000911	0.00109	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—WNT9B—cleft lip	0.000908	0.00109	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—FGFR2—cleft lip	0.000907	0.00109	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Wnt Signaling Pathway—MYC—cleft lip	0.000898	0.00108	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—WNT9B—cleft lip	0.000882	0.00106	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—FGFR3—cleft lip	0.000882	0.00106	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by VEGF—NOS3—cleft lip	0.00088	0.00106	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—FGFR3—cleft lip	0.000877	0.00105	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—TCN2—cleft lip	0.000875	0.00105	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—FGFR3—cleft lip	0.000873	0.00105	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—NOG—cleft lip	0.00087	0.00104	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—FGFR3—cleft lip	0.000869	0.00104	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—FGFR1—cleft lip	0.000865	0.00104	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—FGFR1—cleft lip	0.000865	0.00104	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—FGFR1—cleft lip	0.000857	0.00103	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—FGFR1—cleft lip	0.00085	0.00102	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—FGFR1—cleft lip	0.000846	0.00102	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—FGFR2—cleft lip	0.000822	0.000987	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—FGFR3—cleft lip	0.000817	0.000982	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—FGFR3—cleft lip	0.000817	0.000982	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—FGFR1—cleft lip	0.000814	0.000977	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—FGFR3—cleft lip	0.00081	0.000973	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—ABCA4—cleft lip	0.000809	0.000971	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—SUMO1—cleft lip	0.000806	0.000968	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—FGFR3—cleft lip	0.000803	0.000964	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—FGFR3—cleft lip	0.000799	0.00096	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—FGF10—cleft lip	0.000788	0.000946	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—FGF10—cleft lip	0.000782	0.000939	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—FGFR1—cleft lip	0.000766	0.00092	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—FGF2—cleft lip	0.000758	0.00091	CbGpPWpGaD
Ingenol Mebutate—PRKCD—MAPK Signaling Pathway—MYC—cleft lip	0.00075	0.0009	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—FGF2—cleft lip	0.000749	0.0009	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—WNT9B—cleft lip	0.000744	0.000894	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—FGF7—cleft lip	0.000737	0.000886	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—FGF7—cleft lip	0.000727	0.000873	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling of activated FGFR—FGF2—cleft lip	0.000725	0.000871	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—FGFR3—cleft lip	0.000724	0.000869	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—WNT3—cleft lip	0.000721	0.000866	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—WNT3—cleft lip	0.000701	0.000842	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Myometrial Relaxation and Contraction Pathways—NOS3—cleft lip	0.000693	0.000832	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—FGF2—cleft lip	0.000681	0.000818	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—SPRY2—cleft lip	0.000681	0.000818	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—FGF7—cleft lip	0.000681	0.000818	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—FGF8—cleft lip	0.000681	0.000817	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—FGF2—cleft lip	0.000678	0.000814	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—IRF6—cleft lip	0.000676	0.000811	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—FGF2—cleft lip	0.000675	0.00081	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—FGF2—cleft lip	0.000671	0.000806	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—FGF8—cleft lip	0.000671	0.000806	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—PTCH1—cleft lip	0.000669	0.000803	CbGpPWpGaD
Ingenol Mebutate—PRKCA—EGF/EGFR Signaling Pathway—NOS3—cleft lip	0.000669	0.000803	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—ABCA4—cleft lip	0.000663	0.000797	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Wnt Signaling Pathway and Pluripotency—MYC—cleft lip	0.000642	0.000771	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—FGFR2—cleft lip	0.000632	0.000759	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—FGF2—cleft lip	0.000632	0.000759	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—FGF2—cleft lip	0.000632	0.000759	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—FGF8—cleft lip	0.000628	0.000755	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—FGFR2—cleft lip	0.000628	0.000754	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—FGF2—cleft lip	0.000626	0.000752	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—FGF2—cleft lip	0.00062	0.000745	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—FGF2—cleft lip	0.000618	0.000742	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—SLC19A1—cleft lip	0.000607	0.000729	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—MTR—cleft lip	0.000607	0.000729	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—FGF2—cleft lip	0.000594	0.000714	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—WNT3—cleft lip	0.000591	0.00071	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—FGFR1—cleft lip	0.000589	0.000707	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—FGFR1—cleft lip	0.000585	0.000703	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—MYC—cleft lip	0.000571	0.000686	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—FGF2—cleft lip	0.000559	0.000672	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—FGFR3—cleft lip	0.000557	0.000669	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—FGF3—cleft lip	0.000554	0.000665	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—FGFR3—cleft lip	0.000553	0.000664	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—FGF3—cleft lip	0.000546	0.000656	CbGpPWpGaD
Ingenol Mebutate—PRKCA—PDGFR-beta signaling pathway—MYC—cleft lip	0.000545	0.000655	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—FGF9—cleft lip	0.00054	0.000649	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—FGF9—cleft lip	0.000533	0.00064	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—WNT9B—cleft lip	0.000521	0.000626	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—FGF3—cleft lip	0.000511	0.000614	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—SLC19A1—cleft lip	0.000508	0.00061	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—TCN2—cleft lip	0.000503	0.000604	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—NOG—cleft lip	0.0005	0.0006	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—FGF9—cleft lip	0.000499	0.000599	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—FGF7—cleft lip	0.000477	0.000573	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—SPRY2—cleft lip	0.000477	0.000573	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—NOS3—cleft lip	0.000468	0.000562	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—TYMS—cleft lip	0.000466	0.000559	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—ABCA4—cleft lip	0.000465	0.000558	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—SUMO1—cleft lip	0.000463	0.000556	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Extracellular matrix organization—FGF2—cleft lip	0.000459	0.000551	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—FGF10—cleft lip	0.000456	0.000547	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—FGF10—cleft lip	0.000449	0.000539	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—FGF8—cleft lip	0.00044	0.000528	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—FGF2—cleft lip	0.00043	0.000517	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—FGF2—cleft lip	0.000427	0.000513	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—FGF7—cleft lip	0.000424	0.000509	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—TCN2—cleft lip	0.000421	0.000506	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—FGF10—cleft lip	0.000421	0.000505	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—TYMS—cleft lip	0.000416	0.0005	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—WNT3—cleft lip	0.000414	0.000497	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—PTCH1—cleft lip	0.000395	0.000474	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—FGF7—cleft lip	0.000391	0.00047	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—SPRY2—cleft lip	0.000391	0.00047	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—FGF8—cleft lip	0.000391	0.000469	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—MYC—cleft lip	0.000389	0.000467	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—PTCH1—cleft lip	0.000384	0.000461	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—FGFR2—cleft lip	0.000366	0.000439	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—FGF8—cleft lip	0.000361	0.000433	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—FGFR2—cleft lip	0.000361	0.000433	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—FGF3—cleft lip	0.000358	0.00043	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—FGF9—cleft lip	0.000349	0.000419	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—MTR—cleft lip	0.000349	0.000419	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—FGFR1—cleft lip	0.000341	0.000409	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—FGFR2—cleft lip	0.000338	0.000405	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—FGFR1—cleft lip	0.000336	0.000404	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—MTHFR—cleft lip	0.000325	0.00039	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—FGFR3—cleft lip	0.000322	0.000387	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—FGF3—cleft lip	0.000318	0.000382	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—FGFR3—cleft lip	0.000318	0.000381	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—FGFR1—cleft lip	0.000315	0.000378	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—FGF9—cleft lip	0.00031	0.000373	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—FGFR3—cleft lip	0.000297	0.000357	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—FGF10—cleft lip	0.000295	0.000354	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—FGF3—cleft lip	0.000294	0.000353	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—MTR—cleft lip	0.000292	0.000351	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—FGF9—cleft lip	0.000286	0.000344	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—SPRY2—cleft lip	0.000274	0.000329	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—FGF7—cleft lip	0.000274	0.000329	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—NOS3—cleft lip	0.000269	0.000323	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—FGF10—cleft lip	0.000262	0.000314	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by Wnt—MYC—cleft lip	0.000259	0.000311	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—FGF8—cleft lip	0.000253	0.000303	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—FGF2—cleft lip	0.000249	0.000299	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—FGF2—cleft lip	0.000245	0.000295	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—FGF10—cleft lip	0.000242	0.00029	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—FGFR2—cleft lip	0.000236	0.000284	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—FGF2—cleft lip	0.00023	0.000276	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PTCH1—cleft lip	0.000227	0.000272	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—NOS3—cleft lip	0.000227	0.000272	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—FGFR1—cleft lip	0.00022	0.000265	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—FGFR2—cleft lip	0.00021	0.000252	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—FGFR3—cleft lip	0.000208	0.00025	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—FGF3—cleft lip	0.000206	0.000247	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—FGF9—cleft lip	0.000201	0.000241	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—FGFR1—cleft lip	0.000196	0.000235	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—FGFR2—cleft lip	0.000194	0.000233	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—MYC—cleft lip	0.000188	0.000226	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—MTHFR—cleft lip	0.000187	0.000224	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—FGFR3—cleft lip	0.000185	0.000222	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—FGFR1—cleft lip	0.000181	0.000217	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—TYMS—cleft lip	0.000179	0.000215	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—FGFR3—cleft lip	0.000171	0.000205	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—FGF10—cleft lip	0.000169	0.000203	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—MYC—cleft lip	0.000168	0.000202	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—MYC—cleft lip	0.000162	0.000194	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—FGF2—cleft lip	0.000161	0.000193	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—NOS3—cleft lip	0.000159	0.000191	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—MTHFR—cleft lip	0.000156	0.000188	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—MYC—cleft lip	0.00015	0.00018	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—FGF2—cleft lip	0.000143	0.000172	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—FGFR2—cleft lip	0.000136	0.000163	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—FGF2—cleft lip	0.000132	0.000158	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—NOS3—cleft lip	0.00013	0.000156	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—FGFR1—cleft lip	0.000127	0.000152	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—FGFR3—cleft lip	0.00012	0.000144	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—NOS3—cleft lip	0.000109	0.000131	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—MYC—cleft lip	0.000105	0.000126	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—MYC—cleft lip	9.29e-05	0.000112	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—FGF2—cleft lip	9.24e-05	0.000111	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—NOS3—cleft lip	9.11e-05	0.000109	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—MYC—cleft lip	8.63e-05	0.000104	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—MYC—cleft lip	6.04e-05	7.26e-05	CbGpPWpGaD
